nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—CYP4A11—Dexamethasone—ankylosing spondylitis	0.136	0.17	CbGbCtD
Cisplatin—BCHE—Triamcinolone—ankylosing spondylitis	0.0765	0.0958	CbGbCtD
Cisplatin—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0596	0.0745	CbGbCtD
Cisplatin—PTGS2—Triamcinolone—ankylosing spondylitis	0.0589	0.0737	CbGbCtD
Cisplatin—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0589	0.0737	CbGbCtD
Cisplatin—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0539	0.0674	CbGbCtD
Cisplatin—ABCC3—Methotrexate—ankylosing spondylitis	0.0526	0.0658	CbGbCtD
Cisplatin—PTGS2—Betamethasone—ankylosing spondylitis	0.0505	0.0632	CbGbCtD
Cisplatin—ABCC2—Dexamethasone—ankylosing spondylitis	0.0297	0.0372	CbGbCtD
Cisplatin—PTGS2—Dexamethasone—ankylosing spondylitis	0.0294	0.0368	CbGbCtD
Cisplatin—ABCG2—Dexamethasone—ankylosing spondylitis	0.0269	0.0336	CbGbCtD
Cisplatin—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0256	0.0321	CbGbCtD
Cisplatin—ABCC2—Methotrexate—ankylosing spondylitis	0.0239	0.0299	CbGbCtD
Cisplatin—ABCG2—Methotrexate—ankylosing spondylitis	0.0216	0.027	CbGbCtD
Cisplatin—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0189	0.0237	CbGbCtD
Cisplatin—ABCB1—Betamethasone—ankylosing spondylitis	0.0167	0.0209	CbGbCtD
Cisplatin—ABCB1—Prednisolone—ankylosing spondylitis	0.0164	0.0206	CbGbCtD
Cisplatin—ABCB1—Prednisone—ankylosing spondylitis	0.0155	0.0194	CbGbCtD
Cisplatin—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00999	0.0125	CbGbCtD
Cisplatin—ABCB1—Dexamethasone—ankylosing spondylitis	0.0097	0.0121	CbGbCtD
Cisplatin—ABCB1—Methotrexate—ankylosing spondylitis	0.00779	0.00975	CbGbCtD
Cisplatin—MPO—IL23-mediated signaling events—IL23R—ankylosing spondylitis	0.00274	0.0777	CbGpPWpGaD
Cisplatin—ATP7B—Ion channel transport—ANO6—ankylosing spondylitis	0.00249	0.0704	CbGpPWpGaD
Cisplatin—ATP7A—Ion channel transport—ANO6—ankylosing spondylitis	0.00211	0.0599	CbGpPWpGaD
Cisplatin—MT2A—Interferon gamma signaling—HLA-C—ankylosing spondylitis	0.0013	0.0368	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—IL17A—ankylosing spondylitis	0.00109	0.0309	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—IL12B—ankylosing spondylitis	0.00102	0.0287	CbGpPWpGaD
Cisplatin—ATP7B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000865	0.0245	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000831	0.0235	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—IL10—ankylosing spondylitis	0.000798	0.0226	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.000777	0.022	CbGpPWpGaD
Cisplatin—MT2A—Interferon gamma signaling—HLA-B—ankylosing spondylitis	0.000768	0.0217	CbGpPWpGaD
Cisplatin—ATP7A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000736	0.0208	CbGpPWpGaD
Cisplatin—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000734	0.159	CbGdCrCtD
Cisplatin—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000723	0.156	CbGdCrCtD
Cisplatin—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000723	0.156	CbGdCrCtD
Cisplatin—MT2A—Interferon gamma signaling—HLA-A—ankylosing spondylitis	0.000711	0.0201	CbGpPWpGaD
Cisplatin—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000706	0.153	CbGdCrCtD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000705	0.02	CbGpPWpGaD
Cisplatin—ABCC6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000705	0.02	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	0.000703	0.0199	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-C—ankylosing spondylitis	0.000634	0.018	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.000553	0.0157	CbGpPWpGaD
Cisplatin—ABCC5—Defective B3GAT3 causes JDSSDHD—B3GNT2—ankylosing spondylitis	0.000532	0.0151	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.000483	0.0137	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—CRP—ankylosing spondylitis	0.00045	0.0127	CbGpPWpGaD
Cisplatin—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000443	0.0957	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000436	0.0942	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000436	0.0942	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000426	0.092	CbGdCrCtD
Cisplatin—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.000426	0.0121	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.000423	0.012	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KIR3DL1—ankylosing spondylitis	0.000419	0.0119	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—CRP—ankylosing spondylitis	0.000393	0.0111	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-B—ankylosing spondylitis	0.000375	0.0106	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.000368	0.0104	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000358	0.0101	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-A—ankylosing spondylitis	0.000347	0.00984	CbGpPWpGaD
Cisplatin—PTGS2—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000346	0.00978	CbGpPWpGaD
Cisplatin—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000331	0.00206	CcSEcCtD
Cisplatin—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00033	0.00206	CcSEcCtD
Cisplatin—ABCC5—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000324	0.00917	CbGpPWpGaD
Cisplatin—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000324	0.00202	CcSEcCtD
Cisplatin—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000324	0.00202	CcSEcCtD
Cisplatin—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000322	0.002	CcSEcCtD
Cisplatin—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000322	0.002	CcSEcCtD
Cisplatin—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000322	0.002	CcSEcCtD
Cisplatin—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000322	0.002	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000321	0.002	CcSEcCtD
Cisplatin—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000319	0.00199	CcSEcCtD
Cisplatin—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000319	0.00199	CcSEcCtD
Cisplatin—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000319	0.00198	CcSEcCtD
Cisplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TNF—ankylosing spondylitis	0.000317	0.00897	CbGpPWpGaD
Cisplatin—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.000317	0.00197	CcSEcCtD
Cisplatin—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000316	0.00197	CcSEcCtD
Cisplatin—Pancreatitis—Prednisone—ankylosing spondylitis	0.000315	0.00196	CcSEcCtD
Cisplatin—Sweating increased—Prednisone—ankylosing spondylitis	0.000313	0.00195	CcSEcCtD
Cisplatin—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000312	0.00195	CcSEcCtD
Cisplatin—MPO—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000312	0.00884	CbGpPWpGaD
Cisplatin—Erythema—Prednisolone—ankylosing spondylitis	0.000308	0.00192	CcSEcCtD
Cisplatin—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000303	0.00189	CcSEcCtD
Cisplatin—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000301	0.00187	CcSEcCtD
Cisplatin—Bradycardia—Betamethasone—ankylosing spondylitis	0.0003	0.00187	CcSEcCtD
Cisplatin—Bradycardia—Dexamethasone—ankylosing spondylitis	0.0003	0.00187	CcSEcCtD
Cisplatin—Irritability—Methotrexate—ankylosing spondylitis	0.000296	0.00184	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000295	0.00836	CbGpPWpGaD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000293	0.0083	CbGpPWpGaD
Cisplatin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000293	0.00182	CcSEcCtD
Cisplatin—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000292	0.00182	CcSEcCtD
Cisplatin—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00029	0.00181	CcSEcCtD
Cisplatin—Vision blurred—Prednisolone—ankylosing spondylitis	0.00029	0.00181	CcSEcCtD
Cisplatin—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00029	0.0018	CcSEcCtD
Cisplatin—ABCC5—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000286	0.00809	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000285	0.00178	CcSEcCtD
Cisplatin—Visual impairment—Betamethasone—ankylosing spondylitis	0.000284	0.00177	CcSEcCtD
Cisplatin—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000284	0.00177	CcSEcCtD
Cisplatin—Erythema—Triamcinolone—ankylosing spondylitis	0.000283	0.00176	CcSEcCtD
Cisplatin—MPO—IL23-mediated signaling events—TNF—ankylosing spondylitis	0.000283	0.008	CbGpPWpGaD
Cisplatin—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000282	0.00176	CcSEcCtD
Cisplatin—Erythema—Methylprednisolone—ankylosing spondylitis	0.000282	0.00176	CcSEcCtD
Cisplatin—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000282	0.00176	CcSEcCtD
Cisplatin—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00028	0.00175	CcSEcCtD
Cisplatin—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00028	0.00175	CcSEcCtD
Cisplatin—Breast disorder—Methotrexate—ankylosing spondylitis	0.00028	0.00175	CcSEcCtD
Cisplatin—Malaise—Prednisolone—ankylosing spondylitis	0.000277	0.00173	CcSEcCtD
Cisplatin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000276	0.00172	CcSEcCtD
Cisplatin—Eye disorder—Betamethasone—ankylosing spondylitis	0.000276	0.00172	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000273	0.00772	CbGpPWpGaD
Cisplatin—Convulsion—Prednisolone—ankylosing spondylitis	0.000267	0.00166	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.000265	0.00749	CbGpPWpGaD
Cisplatin—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000263	0.00164	CcSEcCtD
Cisplatin—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000263	0.00164	CcSEcCtD
Cisplatin—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000263	0.00164	CcSEcCtD
Cisplatin—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000262	0.00163	CcSEcCtD
Cisplatin—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000262	0.00163	CcSEcCtD
Cisplatin—Bradycardia—Prednisone—ankylosing spondylitis	0.000261	0.00163	CcSEcCtD
Cisplatin—Alopecia—Dexamethasone—ankylosing spondylitis	0.000261	0.00162	CcSEcCtD
Cisplatin—Alopecia—Betamethasone—ankylosing spondylitis	0.000261	0.00162	CcSEcCtD
Cisplatin—Discomfort—Prednisolone—ankylosing spondylitis	0.000259	0.00161	CcSEcCtD
Cisplatin—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000257	0.0016	CcSEcCtD
Cisplatin—Erythema—Dexamethasone—ankylosing spondylitis	0.000257	0.0016	CcSEcCtD
Cisplatin—Erythema—Betamethasone—ankylosing spondylitis	0.000257	0.0016	CcSEcCtD
Cisplatin—Malaise—Triamcinolone—ankylosing spondylitis	0.000255	0.00159	CcSEcCtD
Cisplatin—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000255	0.00159	CcSEcCtD
Cisplatin—Malaise—Methylprednisolone—ankylosing spondylitis	0.000255	0.00158	CcSEcCtD
Cisplatin—MT2A—Immune System—IL1R2—ankylosing spondylitis	0.000254	0.00719	CbGpPWpGaD
Cisplatin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000252	0.00157	CcSEcCtD
Cisplatin—Oedema—Prednisolone—ankylosing spondylitis	0.000251	0.00156	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000251	0.00156	CcSEcCtD
Cisplatin—SOD1—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00025	0.00709	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.00025	0.00709	CbGpPWpGaD
Cisplatin—Convulsion—Triamcinolone—ankylosing spondylitis	0.000245	0.00153	CcSEcCtD
Cisplatin—Tachycardia—Prednisolone—ankylosing spondylitis	0.000245	0.00153	CcSEcCtD
Cisplatin—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000245	0.00152	CcSEcCtD
Cisplatin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000243	0.00151	CcSEcCtD
Cisplatin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000241	0.0015	CcSEcCtD
Cisplatin—MT2A—Immune System—ERAP1—ankylosing spondylitis	0.000241	0.00682	CbGpPWpGaD
Cisplatin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00024	0.0015	CcSEcCtD
Cisplatin—Eye disorder—Prednisone—ankylosing spondylitis	0.00024	0.00149	CcSEcCtD
Cisplatin—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000239	0.00149	CcSEcCtD
Cisplatin—ABCC3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000239	0.00676	CbGpPWpGaD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000239	0.00149	CcSEcCtD
Cisplatin—Flushing—Prednisone—ankylosing spondylitis	0.000238	0.00148	CcSEcCtD
Cisplatin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000238	0.00148	CcSEcCtD
Cisplatin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000238	0.00148	CcSEcCtD
Cisplatin—Discomfort—Triamcinolone—ankylosing spondylitis	0.000238	0.00148	CcSEcCtD
Cisplatin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000237	0.00148	CcSEcCtD
Cisplatin—Renal failure—Methotrexate—ankylosing spondylitis	0.000235	0.00146	CcSEcCtD
Cisplatin—Stomatitis—Methotrexate—ankylosing spondylitis	0.000233	0.00145	CcSEcCtD
Cisplatin—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000232	0.00145	CcSEcCtD
Cisplatin—Immune system disorder—Prednisone—ankylosing spondylitis	0.000232	0.00144	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.000232	0.00657	CbGpPWpGaD
Cisplatin—Malaise—Betamethasone—ankylosing spondylitis	0.000231	0.00144	CcSEcCtD
Cisplatin—Malaise—Dexamethasone—ankylosing spondylitis	0.000231	0.00144	CcSEcCtD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000231	0.00655	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000231	0.00655	CbGpPWpGaD
Cisplatin—Oedema—Triamcinolone—ankylosing spondylitis	0.000231	0.00144	CcSEcCtD
Cisplatin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000231	0.00144	CcSEcCtD
Cisplatin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00023	0.00143	CcSEcCtD
Cisplatin—Arrhythmia—Prednisone—ankylosing spondylitis	0.000229	0.00143	CcSEcCtD
Cisplatin—Infection—Triamcinolone—ankylosing spondylitis	0.000229	0.00143	CcSEcCtD
Cisplatin—Infection—Methylprednisolone—ankylosing spondylitis	0.000229	0.00142	CcSEcCtD
Cisplatin—Alopecia—Prednisone—ankylosing spondylitis	0.000227	0.00141	CcSEcCtD
Cisplatin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000226	0.00141	CcSEcCtD
Cisplatin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000226	0.00141	CcSEcCtD
Cisplatin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000225	0.0014	CcSEcCtD
Cisplatin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000225	0.0014	CcSEcCtD
Cisplatin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000225	0.0014	CcSEcCtD
Cisplatin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000224	0.00139	CcSEcCtD
Cisplatin—Malnutrition—Prednisone—ankylosing spondylitis	0.000224	0.00139	CcSEcCtD
Cisplatin—Erythema—Prednisone—ankylosing spondylitis	0.000224	0.00139	CcSEcCtD
Cisplatin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000223	0.00139	CcSEcCtD
Cisplatin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000223	0.00139	CcSEcCtD
Cisplatin—Convulsion—Dexamethasone—ankylosing spondylitis	0.000222	0.00138	CcSEcCtD
Cisplatin—Convulsion—Betamethasone—ankylosing spondylitis	0.000222	0.00138	CcSEcCtD
Cisplatin—MT2A—Immune System—CARD9—ankylosing spondylitis	0.00022	0.00623	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.000219	0.00619	CbGpPWpGaD
Cisplatin—Myalgia—Betamethasone—ankylosing spondylitis	0.000219	0.00136	CcSEcCtD
Cisplatin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000219	0.00136	CcSEcCtD
Cisplatin—Anxiety—Betamethasone—ankylosing spondylitis	0.000218	0.00136	CcSEcCtD
Cisplatin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000218	0.00136	CcSEcCtD
Cisplatin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000216	0.00134	CcSEcCtD
Cisplatin—Discomfort—Betamethasone—ankylosing spondylitis	0.000216	0.00134	CcSEcCtD
Cisplatin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000215	0.00134	CcSEcCtD
Cisplatin—Pain—Prednisolone—ankylosing spondylitis	0.000215	0.00134	CcSEcCtD
Cisplatin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000212	0.00132	CcSEcCtD
Cisplatin—Vision blurred—Prednisone—ankylosing spondylitis	0.000211	0.00131	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00021	0.00131	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00021	0.00131	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00021	0.00131	CcSEcCtD
Cisplatin—Oedema—Betamethasone—ankylosing spondylitis	0.000209	0.0013	CcSEcCtD
Cisplatin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000209	0.0013	CcSEcCtD
Cisplatin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000209	0.0013	CcSEcCtD
Cisplatin—Oedema—Dexamethasone—ankylosing spondylitis	0.000209	0.0013	CcSEcCtD
Cisplatin—Infection—Betamethasone—ankylosing spondylitis	0.000208	0.0013	CcSEcCtD
Cisplatin—Infection—Dexamethasone—ankylosing spondylitis	0.000208	0.0013	CcSEcCtD
Cisplatin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000207	0.00129	CcSEcCtD
Cisplatin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000207	0.00129	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000207	0.00129	CcSEcCtD
Cisplatin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000207	0.00129	CcSEcCtD
Cisplatin—Visual impairment—Methotrexate—ankylosing spondylitis	0.000207	0.00129	CcSEcCtD
Cisplatin—Anaemia—Prednisone—ankylosing spondylitis	0.000207	0.00129	CcSEcCtD
Cisplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—ankylosing spondylitis	0.000207	0.00585	CbGpPWpGaD
Cisplatin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000206	0.00128	CcSEcCtD
Cisplatin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000205	0.00128	CcSEcCtD
Cisplatin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000205	0.00128	CcSEcCtD
Cisplatin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000205	0.00128	CcSEcCtD
Cisplatin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000205	0.00128	CcSEcCtD
Cisplatin—Tachycardia—Betamethasone—ankylosing spondylitis	0.000204	0.00127	CcSEcCtD
Cisplatin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000204	0.00127	CcSEcCtD
Cisplatin—SOD1—Folate Metabolism—TNF—ankylosing spondylitis	0.000204	0.00577	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000203	0.00126	CcSEcCtD
Cisplatin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000203	0.00126	CcSEcCtD
Cisplatin—Malaise—Prednisone—ankylosing spondylitis	0.000202	0.00126	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—ankylosing spondylitis	0.000201	0.00125	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—ankylosing spondylitis	0.0002	0.00125	CcSEcCtD
Cisplatin—Anorexia—Betamethasone—ankylosing spondylitis	0.0002	0.00124	CcSEcCtD
Cisplatin—Anorexia—Dexamethasone—ankylosing spondylitis	0.0002	0.00124	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000199	0.00124	CcSEcCtD
Cisplatin—Pain—Triamcinolone—ankylosing spondylitis	0.000197	0.00123	CcSEcCtD
Cisplatin—Hypotension—Betamethasone—ankylosing spondylitis	0.000196	0.00122	CcSEcCtD
Cisplatin—Hypotension—Dexamethasone—ankylosing spondylitis	0.000196	0.00122	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000194	0.00121	CcSEcCtD
Cisplatin—Convulsion—Prednisone—ankylosing spondylitis	0.000194	0.00121	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000193	0.0012	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000191	0.00119	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000191	0.00119	CcSEcCtD
Cisplatin—Myalgia—Prednisone—ankylosing spondylitis	0.00019	0.00118	CcSEcCtD
Cisplatin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00019	0.00118	CcSEcCtD
Cisplatin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00019	0.00118	CcSEcCtD
Cisplatin—Anxiety—Prednisone—ankylosing spondylitis	0.00019	0.00118	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—ankylosing spondylitis	0.00019	0.00118	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.00019	0.00537	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000189	0.00536	CbGpPWpGaD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000189	0.00118	CcSEcCtD
Cisplatin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000188	0.00117	CcSEcCtD
Cisplatin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000188	0.00117	CcSEcCtD
Cisplatin—Discomfort—Prednisone—ankylosing spondylitis	0.000188	0.00117	CcSEcCtD
Cisplatin—Erythema—Methotrexate—ankylosing spondylitis	0.000187	0.00116	CcSEcCtD
Cisplatin—Malnutrition—Methotrexate—ankylosing spondylitis	0.000187	0.00116	CcSEcCtD
Cisplatin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000185	0.00115	CcSEcCtD
Cisplatin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000183	0.00114	CcSEcCtD
Cisplatin—Oedema—Prednisone—ankylosing spondylitis	0.000182	0.00114	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000182	0.00114	CcSEcCtD
Cisplatin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000182	0.00113	CcSEcCtD
Cisplatin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000182	0.00113	CcSEcCtD
Cisplatin—Infection—Prednisone—ankylosing spondylitis	0.000181	0.00113	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000181	0.00113	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000181	0.00113	CcSEcCtD
Cisplatin—Pain—Dexamethasone—ankylosing spondylitis	0.000179	0.00112	CcSEcCtD
Cisplatin—Pain—Betamethasone—ankylosing spondylitis	0.000179	0.00112	CcSEcCtD
Cisplatin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000179	0.00111	CcSEcCtD
Cisplatin—Tachycardia—Prednisone—ankylosing spondylitis	0.000178	0.00111	CcSEcCtD
Cisplatin—MPO—Folate Metabolism—TNF—ankylosing spondylitis	0.000178	0.00503	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000178	0.00503	CbGpPWpGaD
Cisplatin—Skin disorder—Prednisone—ankylosing spondylitis	0.000177	0.0011	CcSEcCtD
Cisplatin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000176	0.0011	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—ankylosing spondylitis	0.000176	0.0011	CcSEcCtD
Cisplatin—Anorexia—Prednisone—ankylosing spondylitis	0.000174	0.00108	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000173	0.00108	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—ankylosing spondylitis	0.000173	0.00108	CcSEcCtD
Cisplatin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000173	0.00107	CcSEcCtD
Cisplatin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000173	0.00107	CcSEcCtD
Cisplatin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00017	0.00106	CcSEcCtD
Cisplatin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00017	0.00106	CcSEcCtD
Cisplatin—Malaise—Methotrexate—ankylosing spondylitis	0.000168	0.00105	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000167	0.00104	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000166	0.00103	CcSEcCtD
Cisplatin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000166	0.00103	CcSEcCtD
Cisplatin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000166	0.00103	CcSEcCtD
Cisplatin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000166	0.00103	CcSEcCtD
Cisplatin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000165	0.00103	CcSEcCtD
Cisplatin—ABCG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000165	0.00466	CbGpPWpGaD
Cisplatin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000164	0.00102	CcSEcCtD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000163	0.00461	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.000162	0.00458	CbGpPWpGaD
Cisplatin—Convulsion—Methotrexate—ankylosing spondylitis	0.000162	0.00101	CcSEcCtD
Cisplatin—Myalgia—Methotrexate—ankylosing spondylitis	0.000159	0.00099	CcSEcCtD
Cisplatin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000159	0.000987	CcSEcCtD
Cisplatin—Rash—Prednisolone—ankylosing spondylitis	0.000158	0.000986	CcSEcCtD
Cisplatin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000158	0.000985	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000158	0.000983	CcSEcCtD
Cisplatin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000158	0.000981	CcSEcCtD
Cisplatin—Discomfort—Methotrexate—ankylosing spondylitis	0.000157	0.000978	CcSEcCtD
Cisplatin—PTGS2—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000156	0.00443	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000155	0.00439	CbGpPWpGaD
Cisplatin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000152	0.000949	CcSEcCtD
Cisplatin—Infection—Methotrexate—ankylosing spondylitis	0.000151	0.000943	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00015	0.000936	CcSEcCtD
Cisplatin—Asthenia—Betamethasone—ankylosing spondylitis	0.00015	0.000936	CcSEcCtD
Cisplatin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00015	0.000936	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.00015	0.00424	CbGpPWpGaD
Cisplatin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00015	0.000931	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000149	0.000929	CcSEcCtD
Cisplatin—Nausea—Prednisolone—ankylosing spondylitis	0.000149	0.000928	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—ankylosing spondylitis	0.000148	0.000922	CcSEcCtD
Cisplatin—GSTT1—Metabolism—B3GNT2—ankylosing spondylitis	0.000148	0.00418	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000147	0.000918	CcSEcCtD
Cisplatin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000147	0.000914	CcSEcCtD
Cisplatin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000146	0.000912	CcSEcCtD
Cisplatin—Rash—Triamcinolone—ankylosing spondylitis	0.000146	0.000906	CcSEcCtD
Cisplatin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000145	0.000906	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—ankylosing spondylitis	0.000145	0.000905	CcSEcCtD
Cisplatin—Rash—Methylprednisolone—ankylosing spondylitis	0.000145	0.000904	CcSEcCtD
Cisplatin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000145	0.000903	CcSEcCtD
Cisplatin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000144	0.000898	CcSEcCtD
Cisplatin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000143	0.000892	CcSEcCtD
Cisplatin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000143	0.000892	CcSEcCtD
Cisplatin—Hypotension—Methotrexate—ankylosing spondylitis	0.000142	0.000887	CcSEcCtD
Cisplatin—MPO—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.000141	0.004	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000139	0.000865	CcSEcCtD
Cisplatin—MT2A—Immune System—HLA-C—ankylosing spondylitis	0.000138	0.00391	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ANTXR2—ankylosing spondylitis	0.000137	0.00389	CbGpPWpGaD
Cisplatin—Nausea—Triamcinolone—ankylosing spondylitis	0.000137	0.000854	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000137	0.00388	CbGpPWpGaD
Cisplatin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000137	0.000852	CcSEcCtD
Cisplatin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000137	0.000852	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000136	0.000846	CcSEcCtD
Cisplatin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000134	0.000837	CcSEcCtD
Cisplatin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000133	0.000829	CcSEcCtD
Cisplatin—Vomiting—Betamethasone—ankylosing spondylitis	0.000133	0.000829	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000133	0.000825	CcSEcCtD
Cisplatin—Rash—Betamethasone—ankylosing spondylitis	0.000132	0.000822	CcSEcCtD
Cisplatin—Rash—Dexamethasone—ankylosing spondylitis	0.000132	0.000822	CcSEcCtD
Cisplatin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000132	0.000822	CcSEcCtD
Cisplatin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000132	0.000822	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000132	0.00082	CcSEcCtD
Cisplatin—Asthenia—Prednisone—ankylosing spondylitis	0.000131	0.000815	CcSEcCtD
Cisplatin—Pain—Methotrexate—ankylosing spondylitis	0.00013	0.000812	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000127	0.00361	CbGpPWpGaD
Cisplatin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000126	0.000782	CcSEcCtD
Cisplatin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000125	0.000777	CcSEcCtD
Cisplatin—Nausea—Betamethasone—ankylosing spondylitis	0.000124	0.000775	CcSEcCtD
Cisplatin—Nausea—Dexamethasone—ankylosing spondylitis	0.000124	0.000775	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.000123	0.0035	CbGpPWpGaD
Cisplatin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000121	0.00075	CcSEcCtD
Cisplatin—MT2A—Immune System—IL1RN—ankylosing spondylitis	0.00012	0.0034	CbGpPWpGaD
Cisplatin—Vomiting—Prednisone—ankylosing spondylitis	0.000116	0.000722	CcSEcCtD
Cisplatin—Rash—Prednisone—ankylosing spondylitis	0.000115	0.000716	CcSEcCtD
Cisplatin—Dermatitis—Prednisone—ankylosing spondylitis	0.000115	0.000716	CcSEcCtD
Cisplatin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000112	0.000699	CcSEcCtD
Cisplatin—Asthenia—Methotrexate—ankylosing spondylitis	0.000109	0.000681	CcSEcCtD
Cisplatin—Nausea—Prednisone—ankylosing spondylitis	0.000108	0.000675	CcSEcCtD
Cisplatin—MT2A—Immune System—CD79A—ankylosing spondylitis	0.000105	0.00299	CbGpPWpGaD
Cisplatin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000104	0.00065	CcSEcCtD
Cisplatin—PTGS2—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000101	0.00287	CbGpPWpGaD
Cisplatin—Vomiting—Methotrexate—ankylosing spondylitis	9.69e-05	0.000604	CcSEcCtD
Cisplatin—Rash—Methotrexate—ankylosing spondylitis	9.61e-05	0.000599	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—ankylosing spondylitis	9.6e-05	0.000598	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—IL1A—ankylosing spondylitis	9.59e-05	0.00272	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—B3GNT2—ankylosing spondylitis	9.51e-05	0.00269	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	9.37e-05	0.00265	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	9.32e-05	0.00264	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	9.32e-05	0.00264	CbGpPWpGaD
Cisplatin—Nausea—Methotrexate—ankylosing spondylitis	9.06e-05	0.000564	CcSEcCtD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	8.9e-05	0.00252	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	8.86e-05	0.00251	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL1A—ankylosing spondylitis	8.64e-05	0.00245	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD40LG—ankylosing spondylitis	8.59e-05	0.00243	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	8.21e-05	0.00233	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-B—ankylosing spondylitis	8.18e-05	0.00231	CbGpPWpGaD
Cisplatin—ABCC5—Disease—B3GNT2—ankylosing spondylitis	8.09e-05	0.00229	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—B3GNT2—ankylosing spondylitis	8.09e-05	0.00229	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—B3GNT2—ankylosing spondylitis	7.88e-05	0.00223	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	7.71e-05	0.00218	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TLR4—ankylosing spondylitis	7.69e-05	0.00218	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-A—ankylosing spondylitis	7.57e-05	0.00214	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—B3GNT2—ankylosing spondylitis	7.41e-05	0.0021	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CRP—ankylosing spondylitis	7.23e-05	0.00205	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	7.21e-05	0.00204	CbGpPWpGaD
Cisplatin—XDH—Metabolism—B3GNT2—ankylosing spondylitis	7.07e-05	0.002	CbGpPWpGaD
Cisplatin—MT2A—Immune System—TLR4—ankylosing spondylitis	6.93e-05	0.00196	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—B3GNT2—ankylosing spondylitis	6.78e-05	0.00192	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—B3GNT2—ankylosing spondylitis	5.88e-05	0.00166	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ANTXR2—ankylosing spondylitis	5.32e-05	0.00151	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—B3GNT2—ankylosing spondylitis	5e-05	0.00141	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—TNF—ankylosing spondylitis	4.59e-05	0.0013	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—B3GNT2—ankylosing spondylitis	3.82e-05	0.00108	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TNF—ankylosing spondylitis	3.63e-05	0.00103	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	3.55e-05	0.001	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—B3GNT2—ankylosing spondylitis	3.44e-05	0.000975	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—B3GNT2—ankylosing spondylitis	3.41e-05	0.000965	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HLA-A—ankylosing spondylitis	3.27e-05	0.000927	CbGpPWpGaD
Cisplatin—PTGS2—Disease—B3GNT2—ankylosing spondylitis	3.14e-05	0.000888	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—B3GNT2—ankylosing spondylitis	2.63e-05	0.000744	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—B3GNT2—ankylosing spondylitis	2.53e-05	0.000715	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	2.47e-05	0.000699	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	1.86e-05	0.000527	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.75e-05	0.000496	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	1.74e-05	0.000493	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HLA-A—ankylosing spondylitis	1.27e-05	0.000359	CbGpPWpGaD
